| Effects of the Combined Therapy with Raloxifene and Low-Dose Intermittent Fluoride for Two Years in Postmenopausal Women with Osteoporosis. |
|
Chung, Suk Mo , Kim, Ghi Chan |
|
Department of Physical Medicine and Rehabilitation, Kosin University College of Medicine, Korea. jeesang77@hanmail.net |
| 폐경 후 골다공증에서 랄록시펜과 저용량 불소의 2년간 병합요법의 효과 |
|
정석모, 김기찬 |
|
고신대학교 의과대학 재활의학교실 |
|
|
|
|
|
|
| Abstract |
Objective
To compare the effects of raloxifene alone with a combination of raloxifene and fluoride in postmenopausal osteoporosis on bone mineral density, bone turnover and lipid profiles, at 2 year.
Method
Fifty two women with postmenopausal osteoporosis (T-score＜2.5) were studied. Subjects were divided into two groups; Group I (n=23), treated with raloxifene and fluoride, and Group II (n=29), treated with raloxifene alone. Bone mineral density (BMD) at the lumbar spine and femur, osteocalcin, deoxypyridinoline and lipid profiles were measured at baseline and 2 years after treatment.
Results
BMD at the lumbar spine was increased in two groups, and BMD in Group I was increased more than that in Group II. Osteocalcin was increased in Group I, and was decreased in Group II. Deoxypyridinoline was decreased in two groups. Total cholesterol and LDL cholesterol were decreased in two groups, but HDL cholesterol and triglyceride showed no significant change in two groups. There were no significant differences between two groups in lipid profiles.
Conclusion
The combined therapy with raloxifene and low- dose intermittent fluoride was more effective in postmenopausal women with osteoporosis than raloxifene alone, which would not influence on positive effect of raloxifene for lipid metabolism. (J Korean Acad Rehab Med 2007; 31: 207-212) |
| Key Words:
Postmenopausal osteoporosis, Raloxifene, Fluoride |
|
PDF Links
Full text via DOI
Download Citation
